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Abstract
Background: Partner notification is an essential component of sexually transmitted infection (STI) management.
The process involves identifying exposed sex partner(s), notifying these partner(s) about their exposure to a curable
STI, and offering counselling and treatment for the STI as a part of syndromic management or after results from an
STI test. When implemented effectively, partner notification services can prevent the index patient from being
reinfected with a curable STI from an untreated partner, reduce the community burden of curable STIs, and prevent
adverse health outcomes in both the index patient and his or her sex partner(s).
However, partner notification and treatment rates are often low. This study seeks to explore experiences and
preferences related to partner notification and treatment for curable STIs among pregnant women receiving care in
an antenatal clinic with integrated HIV and curable STI testing. Results are intended to inform efforts to improve
partner notification and treatment rates in Southern Africa.
Methods: We conducted qualitative interviews among women diagnosed with Chlamydia trachomatis (CT),
Neisseria gonorrhoeae (NG), and/or Trichomonas vaginalis (TV) infection while seeking antenatal care in Gaborone,
Botswana. Semi-structured interviews were used to obtain women’s knowledge about STIs and their experiences
and preferences regarding partner notification.
Results: Fifteen women agreed to participate in the study. The majority of women had never heard of CT, NG, or
TV infections prior to testing. Thirteen out of 15 participants had notified partners about the STI diagnosis. The
majority of notified partners received some treatment; however, partner treatment was often delayed. Most women
expressed a preference for accompanying partners to the clinic for treatment. Experiences and preferences did not
differ by HIV infection status.
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Conclusions: The integration of STI, HIV, and antenatal care services may have contributed to most women’s
willingness to notify partners. However, logistical barriers to partner treatment remained. More research is needed
to identify effective and appropriate strategies for scaling-up partner notification services in order to improve rates
of partners successfully contacted and treated, reduce rates of STI reinfection during pregnancy, and ultimately
reduce adverse maternal and infant outcomes attributable to antenatal STIs.
Keywords: Partner notification, Treatment, Sexually transmitted infections, Pregnant women, Chlamydia trachomatis,
Neisseria gonorrhoeae, Trichomonas vaginalis, Southern Africa, HIV
Background
Partner notification is an essential component of sexu-
ally transmitted infection (STI) management, including
for HIV and curable infections such as Chlamydia
trachomatis (CT), Neisseria gonorrhoeae (NG), Tricho-
monas vaginalis (TV), and syphilis [1]. The process
involves identifying sex partners, notifying them about
their exposure, and providing counselling and treatment
if appropriate [1, 2]. Partner notification and treatment
reduces the likelihood of re-infecting a treated index
patient, as per-partnership transmission probabilities are
estimated to be high [3], and it may decrease the burden
of infection in communities because the partners may be
asymptomatic and otherwise unlikely to access the
healthcare system for treatment [4–7]. Further, notifying
and treating partners for STIs is critical during antenatal
care. Even curable infections such as CT, NG, and TV
are major causes of morbidity among women and are
associated with adverse perinatal and infant outcomes,
including preterm birth, and mother-to-child transmis-
sion of HIV [7–13].
There are three main approaches to partner notifica-
tion for curable STIs: (1) Health professional-oriented
methods where healthcare workers contact the partner(s)
of the index patient, inform the partner(s) that they have
been exposed to a curable STI, and offer counselling and
treatment for the STI (either directly or through refer-
ral). (2) Patient-oriented methods where the index
patient notifies their partners and encourages them to
seek medical care or provides treatment directly to their
partner(s). (3) Mixed approaches involving both the
index patient and a healthcare provider. For example, an
index patient may be given a deadline to notify their
partner(s) and bring them in for treatment, and if the
deadline is not met, the provider may contact the part-
ner(s) [14]. Regardless of the strategy utilized, the World
Health Organization (WHO) and the Joint United
Nations Programme on HIV/AIDS (UNAIDS) recom-
mend that partner notification for HIV and other STIs
be conducted on a voluntary basis [15].
Among the above-mentioned strategies, none has been
identified as the gold standard and partner notification
rates are often low regardless of the strategy used
[14, 2]. A systematic review, which examined re-
search related to partner notification strategies in
low- and middle-income countries, found that just
over half of partners were notified in the 39 included
studies [2]. In Botswana, our study setting, recent re-
search found that many pregnant women reported
being willing to notify their partners about an STI
diagnosis (90%) [16]. This high level of reported will-
ingness could be related to the fact that Botswana
has a high antenatal HIV prevalence (33%) and HIV
education, opt-out HIV testing, and partner notifica-
tion messages are routinely provided during antenatal
care [17]. However, questions remain about whether
willingness translates to actual notification and sub-
sequent partner treatment.
This study seeks to explore experiences and prefer-
ences related to partner notification and treatment for
curable STIs among pregnant women receiving care in
an antenatal clinic with integrated HIV and curable STI
testing. This qualitative study aims to inform partner
notification services in Southern Africa as well as future
research with a deeper understanding of partner notifi-
cation as a strategy for diagnosing and treating new
cases of STIs and HIV.
Methods
Study setting
Our study took place in an antenatal clinic in Gaborone,
Botswana. In Botswana, antenatal care attendance is
high, more than 92% of antenatal care attendees are
tested for HIV through a routine, opt-out system, and
33% of pregnant women are infected with HIV [18]. The
standard care for curable infections such as CT, NG, and
TV, includes identifying and treating infections based on
symptoms and clinical signs, called syndromic manage-
ment. Partner notification is patient-based, and women
believed to have an STI are encouraged by health pro-
viders to inform their sex partner(s), and are provided
with a contact slip to give to partner(s) that details the
symptom being treated (e.g. abnormal vaginal discharge),
the treatment (e.g. azithromycin), and the date and loca-
tion of treatment [19]. This study was nested within a
CT, NG, and TV infection testing and treatment
Wynn et al. BMC Public Health 2019, 19(Suppl 1):606 Page 2 of 11
intervention (main study) that was integrated into an
antenatal care clinic using the GeneXpert® System (Ce-
pheid, Sunnyvale, CA, USA). The main study offered the
standard care for partner services but differed from syn-
dromic management of STIs by making an etiologic
diagnosis of STIs and treating based on this diagnosis
(not signs and symptoms).
Participant selection and recruitment
Between August 2016–February 2017, a sample of
women who tested positive for CT, NG, or TV at the
Princess Marina Hospital antenatal clinic in Gaborone,
Botswana were recruited by phone for participation in
the qualitative study by a female, Setswana and
English-speaking researcher. In the main study, per the
standard of care in Botswana, after testing positive for
an STI, women received a partner contact slip with
information about the STI they were diagnosed with, the
treatment provided, and space for a partner’s healthcare
provider to sign to confirm that the partner was treated.
Further, women were counselled to notify partners, en-
courage partners to get treatment, and avoid sex for
seven days after treatment [20]. Women were advised to
return for a test of cure after four weeks. In order to
understand a variety of perspectives on partner notifica-
tion, for this qualitative study we aimed to recruit partici-
pants diagnosed with different STIs (e.g. CT, NG, or TV),
with and without HIV coinfection, and who did and did
not tell their partners about their STI diagnosis. All
women were pregnant (< 35 weeks of gestation), at least
18 years of age, and receiving care at Princess Marina at
the time of the STI diagnosis. Those who agreed to par-
ticipate in this qualitative study were scheduled for an
in-person, 30min to 1-h interview in a private office on
the University of Botswana campus or a location of their
choosing. Participants were given a 30 pula (~ 3 USD) re-
imbursement for their transportation. Prior to the inter-
view, participants provided written informed consent.
The interviews were guided by an outline of open-
ended questions and probes that explored the following
domains: participant’s general well-being, sexual rela-
tionship status and history, HIV infection status, experi-
ences with STI testing, partner notification experiences,
barriers and facilitators to notifying their partners, part-
ner reaction and treatment outcomes, and preferences
related to partner notification. The guide was pilot
tested on two participants and revised to improve under-
standing. The study was also temporarily paused after
seven interviews, and transcripts were reviewed to en-
sure the guide was understood and facilitated collection
of detailed and candid information. Each transcript also
included a fieldnotes section where the interviewer
described the setting, rapport with the participant and
any other thoughts relevant to the interview.
Data collection
One-on-one interviews were conducted in Setswana or
English by a female researcher who had a University
degree, training in qualitative methods, and extensive
experience in interviewing on women’s reproductive
health issues. Referrals to health organizations and
community-based services for depression, domestic
violence, or health concerns were provided as needed.
Interviews were digitally recorded, transcribed verba-
tim, and translated to English. As a quality control
check, after seven transcriptions were completed, every
other transcript was selected (3 total) and translated
independently by another member of the study team.
Discrepancies between the two translations were iden-
tified and discussed. However, only minor changes
were made.
Data analysis
To develop a codebook, four transcripts were selected at
random and codes were extracted by two study team
members based on themes included in the interview
guide while also allowing for new codes to emerge in-
ductively from the unique data [21]. The codes were
then compared and aggregated into a master codebook
with codes and definitions. All transcripts were read and
coded using this codebook in Microsoft Word and Excel.
Coded transcripts were assessed for frequently used
codes and patterns associated with women’s experiences
related to partner notification of an STI. Illustrative
quotations were extracted for dominant themes. Diver-
gent or minority views were also noted. Narratives and
themes were compared between participants to under-
stand similarities and differences. Reporting was based
on the consolidated criteria for reporting qualitative
research (COREQ) [22].
Results
Participant characteristics
A convenience sample of 22 women were contacted
and 15 were enrolled in the study. Of the seven who
were not enrolled, four initially agreed and then
continually postponed, two people moved away from
Gaborone, and in one instance, the study interviewer
declined to stay for an interview due to safety
concerns. Characteristics collected at the time of STI
testing, including demographic and relationships
characteristics, HIV infection status, STI-related
symptoms, and self-reported partner notification out-
comes, were compared between those who refused
and enrolled. There did not appear to be any appre-
ciable differences between those who participated and
those who did not participate in terms of age, marital
status, education level, or HIV infection status. Fur-
ther, participants in the qualitative interviews were
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similar in terms of age, HIV-status, and STI-related
symptoms to those diagnosed with a curable STI in
the main study population. Among the seven who did
not enroll, five reported that they told their partners
about the STI diagnosis and one reported that her
partner was not treated (results not shown).
Table 1 describes the age, marital status, highest
education level, HIV infection status, self-reported
STI symptoms, partner notification outcomes, and
test of cure results for the study sample. The mean
age was 29 years, all were unmarried, and 6 (40%)
had achieved a tertiary level of education. The preva-
lence of HIV infection was 40% (6) and almost a
third (4) reported having abnormal vaginal discharge
at time of STI testing. No women reported having
multiple sex partners in the year prior to the STI
diagnosis. Thirteen women reported notifying their
partners about their positive STI diagnosis, and seven
reported that their partners were treated, four said
that their partners were not treated, and four said
that they weren’t sure if their partners were treated.
Three women in the sample retested positive for an
STI at test of cure, which took place four weeks after
initial testing.
Table 2 describes each participant’s STI diagnosis,
HIV infection and partner status, self-reported part-
ner notification and partner treatment outcomes, and
test of cure outcome. Most women in our qualitative
sample were infected with CT-only (9/15) and still in
a relationship with the baby’s father (10/15). The two
women, who did not tell partners about the STI diag-
nosis, were no longer in a relationship with the baby’s
father. Both dissolved their relationships prior to
learning of the STI diagnosis. Four women reported
that their partners were not treated, including two
who were not treated despite being notified. Four
women were unsure if their partners were treated be-
cause they did not have proof (e.g. by accompanying
him to the clinic or being provided with a contact
slip signed by a doctor/nurse). Among the three
women who retested positive for CT at follow-up,
one was unsure if her partner was treated. The time
between initial STI test and interview ranged from 5
to 20 months.
Knowledge about CT, NG, or TV infections
Ten of the 15 women had never heard of CT, NG, or
TV infections prior to testing, including all six of the
women living with HIV. Three women said that they
had heard about the infections, and two reported only
hearing about gonorrhea.
Reasons for testing for CT, NG, or TV infections
When asked about their motivation for STI testing
during their pregnancy, seven women mentioned that
they wanted to test in order to know if they had infec-
tions and expressed an understanding that they could be
infected without knowing.
Because most of the time, we will be living with
infections, but not knowing, so I wanted to see.
(Participant 3, age 27) ***
I felt that it was important to do that [test] because
you never know, maybe some things stay in you, you
can have them without symptoms you see.
(Participant 4, age 33)
Two women said that they tested to protect the baby
from infections. “… for the sake of my baby, so that’s why
I wanted to.” (Participant 2, age 28) Two women said
that it was an opportunity to test that they would not
normally have. Two women reported that they had
symptoms they thought may be a result of an STI or had
been previously treated for an STI and wanted to see if
it they were still infected.
Table 1 Characteristics of women participants in the sexually
transmitted infection partner notification study at Princess
Marina Hospital in Gaborone, Botswana (N = 15)
Study Sample
N (%)
Age in years, Mean (range) 29 (21–35)
Unmarried 15 (100%)
Education
Junior secondary or less 6 (40%)
Senior secondary 3 (20%)
Tertiary 6 (40%)
HIV-infected 6 (40%)
Self-reported STI-related symptoms at time of STI testinga 7 (47%)
Vaginal discharge 4 (57%)
Painful urination 2 (29%)
Lower abdominal pain 3 (43%)
Told partner about STI diagnosis 13 (87%)
Partner treated
Yes 7 (47%)
No (includes those who were not notified) 4 (27%)
Unsure 4 (27%)
STI cured in index participant at follow-up 12 (80%)
Note: aSome women reported more than one symptom. The denominators for
vaginal discharge, painful urination, and lower abdominal pain is the number
of women with any symptomsPercentages may not add up to 100 due
to rounding
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I had challenges of, for two months I used to get itchy
down there and I’d ask myself why, you see.
(Participant 6, age 31)
While only one woman mentioned partner infidelity
as a reason for testing, seven women reported that
their partners were likely having sex with other
women and one woman said “… he is all over the
place. There’s no one that doesn’t know him.” (Partici-
pant 12, age 25) Two women ended relationships
with their partners because they impregnated other
women. Alcohol use was discussed by five women as
a contributor to infidelity. “Yes, when I ask him, he
says he was drunk and didn’t know what he was
doing.” (Participant 1, age 24).
Women’s reaction to STI diagnosis
Four of the 15 women reported that they were “okay”
with their positive STI results or “accepted” them and
did not choose to elaborate further upon probing.
Only a few reported that they were very surprised to
be infected and the remainder expressed relief or an
appreciation for being able to receive treatment for
an infection.
Now, when I was told, I just accepted that, yes,
maybe they’ll help me. I just really wanted help.
(Participant 11, age 21) ***
That’s why I accepted because even if I had received
wrong results [testing positive], I knew I would be
helped, and the baby. (Participant 9, age 28)
Partner notification experiences
Among the 13 women who told their partners about the
STI results, three had recently separated from their
partners and the remainder were still with the partner
who they had been with for one year or longer at the
time of notification. In notifying their partners, most
women told them in person, without much delay from
time of diagnosis and were straightforward in sharing
the news. All but a few women reported using the con-
tact slip to help inform their partners about the STI
results.
I told him that “Mr. I was told that we have
STI’s.” … And again I showed him the clinic
card, because you had marked it somewhere.
(Participant 1, age 24) ***
Yes. I didn’t go around in circles, I got in and
said, I was in [the clinic] and there were people
testing for sexually transmitted diseases so I also
tested, but came back positive. The disease is
called Chlamydia now you can read these
papers and see what kind of disease it is.
(Participant 5, age 35)
The only barrier to notification identified by
women who told their partners was distance, when
the partner lived in another city, which caused
delays in notification. Those who waited did not
want to share this information over the phone. “Hey,
Table 2 Characteristics of women included in the qualitative interview sample
Participant ID STI HIV Infection Status Partner statusa Partner notified Partner treated STI curedb
1 TV Infected No partner No No Yes
2 TV Uninfected New partner No No Yes
3 CT Infected Baby’s father Yes No Yes
4 CT Infected No partner Yes No Yes
5 NG Infected Baby’s father Yes Unsure Yes
6 CT Uninfected Baby’s father Yes Unsure No
7 TV Uninfected Baby’s father Yes Unsure Yes
8 CT Uninfected No partner Yes Unsure Yes
9 CT Uninfected Baby’s father Yes Yes Yes
10 CT Uninfected Baby’s father Yes Yes No
11 CT Uninfected Baby’s father Yes Yes No
12 CT Infected Baby’s father Yes Yes Yes
13 TV Uninfected Baby’s father Yes Yes Yes
14 TV Uninfected Baby’s father Yes Yes Yes
15 CT Infected No partner Yes Yes Yes
Note: a Partner status at time of interview. b Participant retested at four weeks for cure
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[this news is] sensitive and can’t be said over the
phone.” (Participant 7, age 33) One person shared
the results through an image of her medical record
on Whatsapp.
Reasons for telling partners were generally multi-fa-
ceted and included wanting to protect the partner’s
health, prevent reinfection, and not wanting to keep a
secret from the partner.
Because we are together, we sleep together. So obviously,
what I have I must share with him. So that if he also
needs help he may get it. (Participant 4, age 33)
One woman said that counselling provided in the clinic
encouraged her to ensure that her partner was treated.
The advice that [clinic staff] gave me is the one that
gave me that courage to tell them. [They] told me it's
safe to get treated for that and my boyfriend to get
treated…Because there will be no point of me getting
treated and him not. (Participant 11, age 21)
The two women who did not notify their partners
were no longer in a relationship with the baby’s father
at the time that they received the STI results. One
woman did not know how to get in contact with the
partner and one was reluctant to communicate after
the breakup.
Among the six women living with HIV, two were
no longer in relationships and hadn’t notified previ-
ous partners about their HIV status. Four women
living with HIV had notified their current partners
previously about their HIV status. One woman ex-
plained that she had notified all of her sex partners
about her HIV status.
Before I can get into any relationship, whether you judge
me or what, I have to tell you. (Participant 5, age 35)
Despite having increased familiarity with partner
notification due to their HIV status, women living with
HIV infection did not report different experiences with
partner notification compared to those who were
uninfected. All, but one woman with HIV notified their
partners about the curable STI. One woman did not
notify because she was no longer in a relationship.
Partner’s reactions to STI diagnosis
Among participants who notified their partners, the
majority reported that their partners reacted well to
being informed about the STI results. Six women re-
ported that their partners said “it’s okay” or “it will
be fine” after being told about the diagnosis. Two
partners were reported to be scared, one for the
baby’s safety and the other about getting an injection.
One partner made a joke.
“ … Then they found that I have this infection.”
(Starts laughing) Then he just said “it’s loving sex,
that’s the only problem.” (Participant 7, age 33)
One participant reported that her partner reacted in
anger and she had sex with him to calm him down.
I said “I went to [the clinic] for a checkup and then I
checked myself [tested].” Now he is shouting at me for
checking myself … “What did you check for?” saying
“you like testing yourself for so many things!” This and
that. “So you think I sleep around with girls, am I
sick?” Right then we had sex again because he was
shouting right … Yes, I was calming him down.
(Participant 12, age 25)
Some partners asked questions and participants didn’t
have enough information to answer.
I said, “Don’t bother me with too many questions
I don’t want questions, you will ask for yourself.
There’s a lot of time, they give you time to ask.”
(Participant 8, age 31)
He just asked what it was. I said, “I don’t know I’m
asking you, let’s go.” (Participant 1, age 24)
Partner treatment experiences
Women encouraged partners to seek treatment in a
variety of ways. One woman said that she would not
have sex with him until he received treatment, “We are
not going to have sex until you’re tested”, another woman
said,“ if you want a child again let’s go check again for
STI’s” (Participant 5, age 35), and one woman said that
she’s protecting him by telling him to get treated for the
STI, “dude, do you see how much I protect you?” (Partici-
pant 2, age 28) A few partners did not seek treatment
until contacted by clinic staff, at the participant’s
request, to encourage treatment uptake.
So they [partners] come with us. Because when we tell
them they refuse. You see that I asked him and then
after [clinic staff] called that’s when he came.
(Participant 12, age 25)
The two un-notified partners were assumed to be un-
treated. Among the two notified partners that were not
treated, one participant reported that his work schedule
was a barrier to receiving care at a clinic. Another
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woman, who was no longer together with the baby’s
father reported, “it was just laziness,” (Participant 10,
age 32) that prevented her ex-partner from seeking
care. Several women reported that their partners
may not have been treated if the treatment was in-
jection. Several women reported having problems
getting the partner treated when they didn’t have the
contact slip. One partner was confused about what
to say when he arrived at the clinic without a con-
tact slip.
He told me that, when he gets to the hospital what
should he say. And I told him “no when you get to
the hospital, there’s no evidence that I can give you,
when you get to the hospital you tell them my
partner was tested and she was found with STI’s.”
(Participant 5, age 35)
Many women explained that it’s difficult to get male sex
partners to access health care even for HIV testing. For
example, five of 15 women in our sample, including
three women living with HIV, did not know their
partners’ HIV infection status, and reported that their
partners were likely “testing through me.” Several
women mentioned that their partner was unwilling to
get tested because he could check his status when
she got tested.
Yes, because when I said go and test, I tested
myself, he asked me “are you ok” and I said “I’m
fine” then he said “yes that means I’m fine.” Do you
see the issue? (Participant 12, age 25) ***
He is very difficult when it comes to testing. When I go
and test and then show him he believes he is also ok.
(Participant 5, age 35)
Among treated partners, half of the women accompan-
ied them to the clinic. When partners went to the clinic
on their own, some participants had doubts that they
were treated.
I’ll just have to believe I can’t dispute it. [Interviewer:
He hasn’t shown you his card or anything?] No, he
hasn’t shown me. (Participant 9, age 28)
While most women were cured when tested approxi-
mately 4 weeks after STI diagnosis and treatment,
three women retested positive for CT at the first test
of cure. One of these women did not notify her part-
ner after the first diagnosis and had sex without a
condom. Thereafter, she notified him, he was treated,
and her second test of cure was negative. Similarly,
the remaining two women’s partners were treated
only after the first test of cure was positive, and in
both cases clinic staff called to encourage the partners
to seek treatment.
Preferences for notifying partners in the future
Participants were asked questions about how they might
want to notify a partner in the future and different
options were described to them. When asked, in general,
how they would prefer to notify partners in the future,
most women preferred to tell their partner themselves in
person and generally thought the way they told him
went well. Only the woman whose partner was angry
with her upon notification preferred to have a healthcare
provider notify.
Me as a woman, I can tell him. If it’s a problem and
he can’t understand, that’s when I can take him to you
[clinic staff] so you explain what we are talking about.
(Participant 6, age 31)
We also asked how women preferred that partners get
treatment, and described possible options, which in-
cluded: bringing treatment home to partners (e.g.
women would bring information and treatment home
for their partners to take prior to him being examined
by a healthcare provider), have partners go to the clinic
alone (with probing questions on whether a contact
slip was sufficient or if a provider should call), or
accompany partners to the clinic. Most participants
said that they would like to accompany their partners
to the clinic for treatment because many said that
otherwise he may not go.
But if you give me the paper [contact slip] I’m
going to need to go with him because if I don’t he
won’t do it [get treated]. (Participant 10, age 32) ***
I would need me to come with him. If you call him
and say he should come, he is going to agree and not
come. It needs me to say let’s go, they called you.
(Participant 15, age 25)
No women preferred to bring treatment home to their
partners. Two women explained that they would not
want to bring treatment home because the partner
would have many questions or would refuse the treat-
ment.
Ah, it wasn’t going to be good. He was going to
refuse … He was going to ask himself what pills I
was giving to him that he hasn’t been told about.
(Participant 1, age 24)
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Discussion
We assessed pregnant women’s experiences and prefer-
ences associated with partner notification of an STI di-
agnosed during antenatal care in a setting with a high
HIV prevalence. Among our sample of 15 women, most
had never heard of CT, NG, or TV infections before
testing. All but two notified their partners and among
those who notified, distance (e.g. when the partner lived
in another city) was described as a barrier. Most women
used the contact slip to notify their partners and encour-
age them to get treatment. Women who didn’t notify
their partners were no longer in relationships. Just under
half of women reported that their partners were defin-
itely treated, and the remainder said their partners were
not treated or they weren’t certain that their partners
were treated. Women who tested positive for an STI at
the test of cure reported that partners delayed receiving
treatment. Several women needed to have a healthcare
provider call to encourage the partner to get treatment.
Reported barriers to treatment were the partner’s
work schedule and a fear of injections. Many women
reported concerns that their partners were having sex
with other women. In terms of future preferences, all
but one woman reported that they would want to tell
their partner about an STI diagnosis themselves. Most
women would want to accompany their partners to
the clinic for treatment and none would prefer to
take medication home to the partner. Although
women living with HIV may have had more experi-
ence in terms communicating with partners about
STIs compared to uninfected women, their experi-
ences and preferences related to CT, NG, and TV in-
fection notification and treatment did not differ.
We found that pregnant women were willing to notify
their partners about an STI, however, this willingness
did not always result in partners being treated [2].
Motivations from previous qualitative research in South-
ern Africa were similar to our findings in that women
were motivated to tell partners because they thought sex
partners were the source of infection and needed treat-
ment, or to protect a child from infection [23]. However,
barriers to telling partners also included: partners lived
far away, embarrassment, and fearing losing support or
intimate partner violence (IPV) [23, 24]. Although none
of our participants reported IPV, careful monitoring is
still needed, as the prevalence of IPV has been found to
be high in previous studies in Botswana [25, 26]. Settings
with high levels of IPV may consider an IPV screen to
identify women in violent relationships who may not be
able to participate in partner notification programs if
her safety cannot be assured.
Even when partners were treated, several received de-
layed treatment, which puts pregnant women at risk for
reinfection, and reduces the effectiveness of antenatal
STI testing and treatment. A recent modelling study
found that reducing partner treatment from fourteen to
one or two days substantially reduced the risk of CT/NG
reinfection of an index patient [3]. Further, delays in
partner treatment have been previously identified as a
concern in Botswana. A 2013 study assessed contact
slips of partners treated for an STI from approximately
285 health facilities in Botswana to identify any delays
between index patient and partner treatment. This study
found that, among partners who reported for treatment,
22.1% were treated a week or more after the index
patient [27].
In order to improve and expedite partner treatment
rates, several new strategies have been proposed and im-
plemented in other settings, such as the United States
[28]. One strategy is expedited partner therapy, where
an index patient brings medication home to partner(s)
prior to the partner’s evaluation by a healthcare provider
[28]. Several randomized controlled trials have shown
that expedited partner therapy can reduce reinfection
rates compared to simple patient referral (patient tells
sex partners they need to be treated) [29]. One study
involving men and women in the United States, who
were randomized to expedited partner therapy or simple
partner referral, found that 13% of index patients in the
simple referral group had a persistent or recurrent gono-
coccal or chlamydial infection compared to only 10% in
the expedited partner therapy group [30].
However, given that many women in our study
expressed some concerns about expedited partner ther-
apy, decisions about future services should also consider
strategies that ease the burden on women to ensure that
partners are treated, such as provider-based notification
or enhanced patient notification activities, such as
providing additional information about STIs for the
index patient and partner(s). In fact, a systematic review
found that enhanced patient referrals, (including home
sampling kits for partners, educational information for
patients to give to partners, and disease-specific web-
sites) were just as effective at preventing reinfection as
expedited partner treatment [29]. Additionally, a study
in the UK compared time to partner treatment between
routine patient-referral and two accelerated partner
treatment (APT) methods, including: 1) APT Hotline
where partner(s) received assessment and consultation
by healthcare providers over the phone and either
collected treatment at clinic reception or had it delivered
by the index patient. 2) APT Pharmacy where the sex
partner(s) attended a pharmacy for consultation and
treatment [31]. This study found that the median num-
ber of days between index patient diagnosis and sex
partner treatment was shorter for the APT Hotline (1
day, range 10–14 days, p = 0.05) and APT Pharmacy (2
days, range 0–6 days, p = 0.09) compared to routine
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partner notification (3 days, range 0–17) [31]. Such strat-
egies could help address the concern expressed by many
of our participants that they would not be able to answer
all of their partners’ questions.
Participants in our study were unwilling or unable to
notify previous partners about an STI diagnosis, which
is a finding similar to previous research in Southern
Africa [23, 24]. While women are not at risk of reinfec-
tion from ex-partners, not notifying a likely STI case
may represent a missed opportunity to reduce infec-
tions in the community. Studies have estimated that
70–80% of partners of index cases with NG are in-
fected and 60–70% of partners of index cases with
CT are infected [32, 33].
In circumstances where women are unable or unwill-
ing to notify their former partners themselves, it may be
possible for electronic communication technologies to
play a role, such as SMS, or web-based notification.
Although little research has taken place in sub-Saharan
Africa, there is growing research on the acceptability
and utilization of these technologies for STI notifica-
tion [34]. Further, many participants expressed
concerns that their partners may have other casual
sex partners who could potentially also be reached
through electronic communication if their partners
are unwilling to tell them in person. Previous studies
found that referral strategies requiring less interaction,
were preferred for notifying ex-partners or casual
partners [3].
Limitations
The study has some limitations. First, our sample was
small and was derived from a single clinical site that
serves women from Gaborone and southern Botswana.
As previously reported, the sample of women tested for
CT, NG, and TV infections from which women were
recruited for this study had characteristics similar to the
population of pregnant women in Botswana in terms of
age, and marital and HIV status [17, 35]. Second, partici-
pants who participated in the qualitative study may be
different than women who did not with respect to
partner notification. For example, our sample may in-
clude those more willing to discuss partner notifica-
tion because they were more successful in notifying
their partners. Third, response bias is almost always a
limitation when participants are asked sensitive ques-
tions. However, it was encouraging to read in the
transcript fieldnotes sections that our trained inter-
viewer interpreted most women’s responses to be
honest and open. Fourth, our study included only
pregnant women, and findings are not generalizable
to non-pregnant women or men diagnosed with an
STI in Botswana. Previous research has found that
pregnant women may be more likely be in long term
relationships and to notify their partners due to con-
cerns about the baby compared to non-pregnant
women [36].
Similarly, no study participants reported having mul-
tiple sex partners in the year prior to diagnosis. This
finding is not surprising as a previous study found that
only 5% of pregnant women in Gaborone had two or
more partners in the last 12 months [4]. Another, more
recent article, found in a nationally representative sur-
vey that, on average, 6% of (nonpregnant) women re-
ported two or more sexual partners in the past
month [37]. While we were unable to assess experi-
ences and preferences among women with multiple
partners, this issue is critical to consider when imple-
menting new partner notification strategies. Recent
research has highlighted the importance of tailoring
partner notification services to different partner types
(e.g. steady committed, new relationship, occasional,
one-off partner), which may enhance effectiveness and
cost-effectiveness [38].
Finally, it is important to note that this study took
place within a larger STI testing study that deviated
from the standard care in Botswana, syndromic manage-
ment, where curable STIs are treated based on signs and
symptoms [19]. Syndromic management is not sensitive,
missing many infections, and not specific, potentially
overtreating pregnant women [4]. As such, when
index infections are missed, so are those of partners.
Another flaw is that women may be encouraged to
disclose an STI that they don’t have, potentially
exposing them unnecessarily to negative partner
reactions, such as IPV [2].
In Botswana, partner notification services for HIV are
similar to curable STIs. Women who test positive for
HIV are encouraged by health providers to inform their
sex partners, and guidelines call for providers to offer
additional counselling to women who are reluctant or
fearful to disclose [39]. Further, providers are allowed to
inform a woman’s partner only in her presence and upon
her request [39]. Our study highlights the disparity
between men and women in terms of accessing health
services, which has been found in HIV research [40].
This disparity not only puts men’s health at risk as they
are less likely receive HIV testing and treatment [40],
but it also places a burden on women to protect their
partner(s)’ health in order to protect their own. As such,
the enhanced partner notification and provider-based
notification or case finding recommended for curable
STIs may also facilitate notification for HIV. Further, as
management of curable STIs and HIV are continuing to
integrate into antenatal care in Botswana, it may be
possible to harmonize partner notification services to
streamline the process and increase rates of notification
and linkage to care for multiple infections.
Wynn et al. BMC Public Health 2019, 19(Suppl 1):606 Page 9 of 11
Conclusions
In conclusion, the aim of our study was to gain a more
detailed understanding about the experiences and prefer-
ences of pregnant women related to notifying partners
about an STI in a setting with a high antenatal HIV
prevalence. The integration of STI, HIV, and antenatal
care services may have contributed to most women’s
willingness to notify partners. However, logistical bar-
riers to partner treatment remained. In order to im-
prove rates of partner notification and treatment,
reduce rates of re-infection during pregnancy, and
subsequently reduce adverse maternal and infant out-
comes due to antenatal STIs; more research is needed
to identify effective and appropriate strategies for
partner treatment.
A French translation of this article has been included
as Additional file 1.
A Portuguese translation of the abstract has been in-
cluded as Additional file 2.
Additional files
Additional file 1: Translation of this article into French. (PDF 303 kb)
Additional file 2: Translation of the abstract of this article into
Portuguese. (PDF 376 kb)
Abbreviations
APT: Accelerated partner treatment; COREQ: Consolidated criteria for
reporting qualitative research; CT: Chlamydia trachomatis; HIV: Human
immunodeficiency virus; IPV: Intimate partner violence; NG: Neisseria
gonorrhoeae; STI: Sexually transmitted infections; TV: Trichomonas vaginalis;
UNAIDS: Joint United Nations Programme on HIV/AIDS; USD: United States
dollar; WHO: World Health Organization
Acknowledgements
The authors thank the nursing team in the maternal and child health clinic
in Princess Marina Hospital for their support and contribution to the study.
Adriane Wynn was supported by a GloCal fellowship (2D43TW009343-06), a
NIDA-funded T32 training program (T32DA023356), and the Klausner Re-
search and Training Fund. Ogechukwu Agatha Offorjebe was supported by
the David Geffen School of Medicine’s Dean’s Office and the UCLA Center
for World Health. Finally, they thank the patients for their participation.
Funding
The journal supplement is made possible by the generous support of the
American People through the United States Agency for International
Development (USAID) in partnership with United Nations Population Fund
(UNFPA) and The Joint United Nations Program on HIV/AIDS (UNAIDS).
The views expressed in this publication are solely the opinions of the
authors and do not necessarily reflect the official policies of the USAID,
UNFPA or UNAIDS, nor does mention of the department or agency names
imply endorsement by the U.S. Government, UNFPA or UNAIDS.
Availability of data and materials
Not applicable.
About this supplement
This article has been published as part of BMC Public Health, Volume 19
Supplement 1, 2019: Effective Integration of Sexual Reproductive Health and
HIV Prevention, Treatment, and Care Services across sub-Saharan Africa:
Where is the evidence for program implementation? The full contents of the
supplement, published as a joint collaboration between Reproductive Health
and BMC Public Health, are available online at https://bmcpublichealth.
biomedcentral.com/articles/supplements/volume-19-supplement-1 and
https://reproductive-health-journal.biomedcentral.com/articles/supplements/
volume-16-supplement-1
Authors’ contributions
AW, OAO, DRM, CMorroni, and JK contributed to the conception and design
of the study. NM did the acquisition of data. AW, CM, and OAO conducted
the analysis and interpreted the original results. All authors wrote or
reviewed and approved the final manuscript.
Ethics approval and consent to participate
The institutional review boards at the University of Botswana, the Botswana
Ministry of Health, Health Research Development Committee, and Princess
Marina Hospital approved the study protocol. The University of California, Los
Angeles, approved analyses using deidentified data. All study participants
provided written informed consent prior to enrollment. All data from the
interviews were kept confidential and stored in secured locations. During
transcription personal identifiers were removed and documents were labeled
with a study ID. Once transcription was complete, audio files were
destroyed.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1GloCal, University of California Global Health Institute, 550 16th Street, 3rd
Floor, San Francisco, CA 94158, USA. 2Division of Infectious Diseases & Global
Public Health, Department of Medicine, University of California San Diego,
9500 Gilman Drive, La Jolla, CA 92093, USA. 3Fielding School of Public Health,
Department of Health Policy and Management, University of California Los
Angeles, 31-269 CHS, Box 951772, Los Angeles, CA 90095, USA.
4Botswana-UPenn Partnership, UB Main Campus, Gaborone, Botswana.
5David Geffen School of Medicine, University of California Los Angeles, 10833
Le Conte Avenue, Los Angeles, CA 90095, USA. 6Charles R. Drew University of
Medicine and Science, 1731 E 120th St, Los Angeles, CA 90059, USA. 7Faculty
of Medicine, University of Botswana, Gaborone, Botswana. 8Liverpool School
of Tropical Medicine, Liverpool, UK. 9Department of Medicine, University of
Botswana, Gaborone, Botswana. 10Wits Reproductive Health and HIV Institute,
University of Witwatersrand, Johannesburg, South Africa. 11Women’s Health
Research Unit, University of Cape Town, Cape Town, South Africa.
Published: 29 May 2019
References
1. Global Strategy for the Prevention and Control of Sexually Transmitted
Infections: 2006–2015 [https://www.who.int/reproductivehealth/
publications/rtis/9789241563475/en/]. Access date: 3 Sept 2017.
2. Alam N, Chamot E, Vermund S, et al. Partner notification for sexually
transmitted infections in developing countries: a systematic review. BMC
Public Health. 2010;10(19).
3. Althaus CL, Turner KM, Mercer CH, Auguste P, Roberts TE, Bell G, Herzog SA,
Cassell JA, Edmunds WJ, White PJ, et al. Effectiveness and cost-effectiveness
of traditional and new partner notification technologies for curable sexually
transmitted infections: observational study, systematic reviews and
mathematical modelling. Health Technol Assess. 2014;18(2):1–100 vii-viii.
4. Romoren M, Sundby J, Velauthapillai M, Rahman M, Klouman E, Hjortdahl P.
Chlamydia and gonorrhoea in pregnant Batswana women: time to discard
the syndromic approach? BMC Infect Dis. 2007;7:27.
5. Romoren M, Velauthapillai M, Rahman M, Sundby J, Klouman E, Hjortdahl P.
Trichomoniasis and bacterial vaginosis in pregnancy: inadequately managed
with the syndromic approach. Bull World Health Organ. 2007;85(4):297–304.
6. Moodley D, Moodley P, Sebitloane M, Soowamber D, McNaughton-Reyes
HL, Groves AK, Maman S. High prevalence and incidence of asymptomatic
Wynn et al. BMC Public Health 2019, 19(Suppl 1):606 Page 10 of 11
sexually transmitted infections during pregnancy and Postdelivery in
KwaZulu Natal, South Africa. Sex Transm Dis. 2015;42(1):43–7.
7. Mcbride KGR, Fortenberry JD. Formative design and evaluation of patient-
delivered partner therapy informational materials and packaging. Sex
Transm Infect. 2009;85(2):150–5.
8. Gencay M, Koskiniemi M, Ammala P, Fellman V, Narvanen A, Wahlstrom T,
Vaheri A, Puolakkainen M. Chlamydia trachomatis seropositivity is associated
both with stillbirth and preterm delivery. APMIS. 2000;108(9):584–8.
9. Rours GIDL, Moll HA, Arends LR, de Groot R, Jaddoe VW, Hofman A,
Steegers EA, Mackenbach JPOA, Willemse HF, van der Zwaan EA, Verkooijen
RP, Verbrugh HA. Chlamydia trachomatis infection during pregnancy
associated with preterm delivery: a population-based prospective cohort
study. Eur J Epidemiol. 2011;26(6):493–502.
10. Liu BRC, Clarke M, Jorm L, Hunt J, Ward J. Chlamydia and gonorrhoea
infections and the risk of adverse obstetric outcomes: a retrospective cohort
study. Sex Transm Infect. 2013;89(8):672–8.
11. Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH,
Eschenbach DA, Edelman R, Carey JC, Regan JA, et al. Trichomonas vaginalis
associated with low birth weight and preterm delivery. The Vaginal
Infections and Prematurity Study Group. Sex Transm Dis. 1997;24(6):353–60.
12. Fawzi W, Msamanga G, Renjifo B, Spiegelman D, Urassa E, Hashemi L,
Antelman G, Essex M, Hunter D. Predictors of intrauterine and intrapartum
transmission of HIV-1 among Tanzanian women. AIDS. 2001;15(9):1157–65.
13. Grosskurth HGR, Hayes R, Mabey D, Wawer M. Control of sexually
transmitted diseases for HIV-1 prevention: understanding the implications of
the Mwanza and Rakai trial. Lancet. 2001, 1981-1987;355.
14. World Health Organization: Global Strategy for the Prevention and Control of
Sexually Transmitted Infections: 2006–2015 Accessed from: http://www.who.
int/hiv/pub/toolkits/stis_strategy[1]en.pdf 2007. Access date: 8 Jan 2019.
15. Gable L, Gostin L, Hodge J, Gamharter K, Van Puymbroeck R. Legal aspects
of HIV/AIDS: a guide for policy and law reform. Washington: The World
Bank; 2007.
16. Ogechukwu AWA, Moshashane N, Sickboy O, Duque S, Ramogola-Masire D,
Klausner JD, Morroni C. Partner Notificaiton and treatment for sexually
transmitted infections among pregnant women in Gaborone, Botswana. Int
J STD AIDS. 2016; In submission.
17. United Nations Development Programm. HIV/AIDS Overview: Botswana.
http://www.bw.undp.org/content/botswana/en/home/ourwork/hiv_aids/
overview.html. Accessed 24 Apr 2019.
18. United Nations development Programme: HIV/ AIDS overview: Botswana.
[http://www.bw.undp.org/content/botswana/en/home/ourwork/hiv_aids/
overview.html] Access date: 8 Jan 2019.
19. Botswana Ministry of Health: Management of Sexually Transmitted
Infections. Reference manual for health workers. 2012.
20. Wynn A R-MD, Gaolebale P, Doherty K, Moshashane N, Sickboy O, Duque S,
Williams L, Klausner JD, Morroni C.: Prevalence and Correlates of Sexually
Transmitted Infections Among Pregnant Women in Gaborone, Botswana,
2016. Sexually Transmitted Diseases 2016, In submission.
21. Emerson R, Fretz R, Shaw L. Writing ethnographic Fieldnotes. Chicago:
University of Chicago Press; 1995.
22. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative
research (COREQ): a 32-item checklist for interviews and focus groups. Int J
Qual Health Care. 2007;19(6):349–57.
23. Moyo W, Chirenje ZM, Mandel J, Schwarcz SK, Klausner J, Rutherford G,
McFarland W. Impact of a single session of counseling on partner referral
for sexually transmitted disease treatment, Harare, Zimbabwe. AIDS Behav.
2002;6(3):237–43.
24. Harrison A, Lurie M, Wilkinson N. Exploring partner communication and
patterns of sexual networking: qualitative research to improve management
of sexually transmitted diseases. Health Transit Rev. 1997;7(Suppl 3):103–7.
25. Zungu L, Salawu A, O’gunbanjo G. Reported intimate partner violence
amongst women attending a public hospital in Botswana. Afr J Primary
Health Care Family Med. 2010;2(1).
26. Botswana Women’s Affairs Department: Gender Based Violence Indicators
Study Botswana. Accessed from: www.gov.bw/globalassets/mlha/gender-
affairs/final-gbv-indicators-study-pamphlet%2D%2D-botswana.pdf. Access
date: 8 Jan 2019.
27. Tafuma TA, Ntwayagae BC, Moalafhi CK, Bolebantswe JM. Patient-initiated
sexual partner notification in Botswana and time taken for sexual contacts
to report for treatment. S Afr Med J. 2013;104(1):42.
28. Centers for Disease Control and Prevention: Expedited Partner Therapy.
Accessed from: https://www.cdc.gov/std/ept/. Access date: 8 Jan 2019.
29. Ferreira A, Young T, Mathews C, Zunza M, Low N. Strategies for partner
notification for sexually transmitted infections, including HIV. Cochrane
Database Syst Rev. 2013;(10):Cd002843.
30. Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE,
Hogben M, Clark A, Malinski C, Helmers JR, Thomas KK, et al. Effect of
expedited treatment of sex partners on recurrent or persistent gonorrhea or
chlamydial infection. N Engl J Med. 2005;352(7):676–85.
31. Estcourt C, Sutcliffe L, Cassell J, Mercer CH, Copas A, James L, Low N, Horner
P, Clarke M, Symonds M, et al. Can we improve partner notification rates
through expedited partner therapy in the UK? Findings from an exploratory
trial of accelerated partner therapy (APT). Sex Transm Infect. 2012;88(1):21–6.
32. Quinn TC, Gaydos C, Shepherd M, Bobo L, Hook EW 3rd, Viscidi R, Rompalo
A. Epidemiologic and microbiologic correlates of chlamydia trachomatis
infection in sexual partnerships. Jama. 1996;276(21):1737–42.
33. Lycke E, Lowhagen GB, Hallhagen G, Johannisson G, Ramstedt K. The risk of
transmission of genital chlamydia trachomatis infection is less than that of
genital Neisseria gonorrhoeae infection. Sex Transm Dis. 1980;7(1):6–10.
34. Pellowski J, Mathews C, Kalichman MO, Dewing S, Lurie MN, Kalichman SC.
Advancing partner notification through electronic communication
technology: a review of acceptability and utilization research. J Health
Commun. 2016;21(6):629–37.
35. Botswana Central Statistical Office and UNICEF: 2007 Botswana family health
survey IV report. Gaborone 2009.
36. Garcia PJ, Williams E, Carcamo CP, Chiappe M, Holmes KK, Peeling RW,
Mabey DM. Partner notification among Peruvian pregnant women with
syphilis. Sex Transm Dis. 2015;42(8):457–62.
37. Ho-Foster A, Laetsang D, Masisi M, Anderson M, Tlhoiwe D, Cockcroft A,
Andersson N. Gender-specific patterns of multiple concurrent sexual
partnerships: a national cross sectional survey in Botswana. AIDS Care. 2010;
22(8):1006–11.
38. Estcourt C: Going beyond “regular and casual”: developing a new sex
partner classification to enable prioritisation of resources and tailoring of
partner notification. Presentation at the IUSTI World & European Conference
2018, June 2018.(Dublin, Ireland.).
39. Botswana Ministry of Health: National Guidelines: HIV Testing and
Counselling. 2009.
40. Baker P, Dworkin SL, Tong S, Banks I, Shand T, Yamey G. The men’s health
gap: men must be included in the global health equity agenda. Bull World
Health Organ. 2014;92(8):618–20.
Wynn et al. BMC Public Health 2019, 19(Suppl 1):606 Page 11 of 11
